Encube Ethicals Limited (38508932)
IPO (In Principle): Encube Ethicals Limited
📋 IPO IN-PRINCIPLE APPROVAL — Encube Ethicals Limited
_Encube Ethicals Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients in India_
Issue Size: ₹30.00bn
Est. Mcap: ₹10,000–20,000cr
Face Value: ₹1
Industry: Pharmaceuticals & Biotechnology
Exchange: BSE And NSE
Promoters: Mehul Madhusudan Shah
BRLM: Other LM / BRLM, Axis Capital Limited, Kotak Mahindra Capital Company Limited
Eligibility: Regulation 6(1)
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 38508932 — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add 38508932 to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Encube Ethicals Limited
Important.
The summary above is generated automatically from Encube Ethicals Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.